LifeVantage Corporation (LFVN) financial statements and ratios from SEC XBRL: revenue $228.53M (TTM), net margin 4.3%, revenue growth -25.2% YoY, P/E 11.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $228.53M |
| Net Margin | 4.3% |
| Revenue Growth (YoY) | -25.2% |
| EPS Growth (YoY) | -60.7% |
| FCF Growth (YoY) | -69.6% |
| P/E Ratio | 11.6 |
| EV / EBITDA | 4.8 |
| Price / Book | 2.52 |
| Price / Sales | 0.42 |
| FCF Yield | 10.5% |
| DCF Value (model) | $41.82 |
| DCF Upside vs Price | 527.9% |
| Altman Z-Score | 3.46 (safe) |
| Sector P/E (Healthcare) | 21.7 |
LFVN overview · LFVN earnings · LFVN KPIs · LFVN investor relations · LFVN ownership · LFVN peers · LFVN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.